Ocular neuromyotonia is a rare, albeit treatable, ocular motor disorder, characterised by recurrent brief episodes of diplopia due to tonic extraocular muscle contraction. Ephaptic transmission in a chronically damaged ocular motor nerve is the possible underlying mechanism. It usually improves with carbamazepine. A 53-year-old woman presented with a 4-month history of recurrent episodes of binocular vertical diplopia (up to 40/day), either spontaneously or after sustained downward gaze. Between episodes she had a mild left fourth nerve palsy. Sustained downward gaze consistently triggered downward left eye tonic deviation, lasting around 1 min. MR scan of the brain was normal. She improved on starting carbamazepine but developed a rash that necessitated stopping the drug. Switching to lacosamide controlled her symptoms.
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Discussion
Ocular neuromyotonia is a rare yet treatable cause of transient diplopia. It is due to a spasm of one or more extraocular muscles that may occur spontaneously and after holding eccentric gaze. 1 It can involve any extraocular muscle, including the levator palpebrae superioris, and lasts between seconds and 3-4 min. 2 It most commonly occurs in the setting of cranial irradiation, nerve compression of vascular or meningeal origin, and autoimmune disorders (eg, myasthenia gravis and thyroid eye disease). 1 Many cases are idiopathic and are frequently accompanied by mild paresis of the affected muscle in between episodes, 2 as in this case. The pathophysiology probably relates to nerve demyelination and ephaptic transmission, although repatterning of central circuits and a mechanism similar to that of systemic neuromyotonia (ie, calcium channel dysfunction) are alternative causes. 2 As in other ephaptic transmission conditions, voltage-gated sodium channel (VGSC) blockers (ie, carbamazepine, oxcarbazepine, phenytoin, lamotrigine) are recommended, although a few reported refractory cases undergo surgical microvascular decompression. 3 In this case, given the occurrence of a carbamazepine-induced cutaneous adverse reaction, we considered lacosamide, given the risk of adverse drug reaction with other VGSC blockers, its low risk of cross-reactivity, side-effect profile and action mechanism. Specifically, both carbamazepine and lacosamide act on the VGSC. However, carbamazepine stabilises the channel in the fast-inactivating phase in a use-dependent fashion, while lacosamide stabilises it in the slow-inactivating phase, with weak use dependence, thus decreasing VGSC availability. 4 Furthermore, carbamazepine may also act on calcium channels, while lacosamide appears to have no effect on those channels. 4 Although the clinical correlate of these physiological differences is elusive, efficacy in this patient was not hampered by the differences in mechanism of action.
In conclusion, this case illustrates ocular neuromyotonia as a rare cause of transient diplopia, which fully responded to lacosamide. Our observation expands the therapeutic armamentarium for ocular neuromyotonia.
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Key Points
► Ocular neuromyotonia is characterised by tonic spasms involving one or more extraocular muscles. ► Ocular neuromyotonia should be considered in the differential diagnosis of recurrent diplopia, particularly when following previous nerve injury. ► Patients with suspected ocular neuromyotonia should undergo MR scan of the brain to exclude secondary causes of ocular neuromyotonia. ► Ocular neuromyotonia responds to carbamazepine, although other sodium channel blockers, including lacosamide, may be effective.
Referee's comment
We asked Dr Mark Lawden, who refereed this paper, to help readers to distinguish between ocular neuromyotonia and superior oblique myokymia. Here is his reply ____________________________ In ocular neuromyotonia the eye gets temporarily stuck after looking in the direction of the affected muscle causing sustained diplopia on looking back the primary position. This gradually goes off after a minute or two as in the video in this paper. The cause may be compression, prior irradiation or idiopathic.
https://www.youtube.com/watch?v=0NAb70xWZjQ (accessed 15/02/2018) In superior oblique myokymia there are repetitive very brief torsional movements of the eye causing brief vertical diplopia. The cause is probably microvascular compression as with trigeminal neuralgia and hemifacial spasm.
https://www.youtube.com/watch?v=HwsJvCOC6_Q (accessed 15/02/2018)
You can just about see it in the above video clip (it's very subtle).
